Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients | Zendy

C. Schvartz | Zendy; Franck Bonnetain | Zendy; Tienhan Sandrine DabakuyoYonli | Zendy; Mélanie Gauthier | Zendy; A. Cueff | Zendy; S. Fieffé | Zendy; Jean-Marie Pochart | Zendy; I. Cochet | Zendy; E. Crevisy | Zendy; A. Dalac | Zendy; Dimitri Papathanassiou | Zendy; Michel Toubeau | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients

Author(s) -

C. Schvartz,

Franck Bonnetain,

Tienhan Sandrine DabakuyoYonli,

Mélanie Gauthier,

A. Cueff,

S. Fieffé,

Jean-Marie Pochart,

I. Cochet,

E. Crevisy,

A. Dalac,

Dimitri Papathanassiou,

Michel Toubeau

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-2512

Subject(s) - medicine , hazard ratio , thyroid cancer , proportional hazards model , propensity score matching , confidence interval , univariate analysis , multivariate analysis , thyroid , surgery

American Thyroid Association and European Thyroid Association guidelines cannot recommend for or against radioactive iodine (RAI) ablation after surgery in low-risk differentiated thyroid cancer (DTC) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research